Zolpidem

Generic Name
Zolpidem
Brand Names
Ambien, Edluar, Intermezzo, Tovalt
Drug Type
Small Molecule
Chemical Formula
C19H21N3O
CAS Number
82626-48-0
Unique Ingredient Identifier
7K383OQI23
Background

Zolpidem, also known as Ambien, is a hypnotic drug that was initially approved by the FDA in 1992 . Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the time to fall asleep (sleep latency), increases the duration of sleep, and decreases the number of awakenings during s...

Indication

This drug is indicated for the short-term treatment of insomnia in adults characterized by difficulties with sleep initiation .

Associated Conditions
Insomnia
Associated Therapies
-
nypost.com
·

New 'natural' sleep supplement designed by anesthesiologist

Dr. David Mahjoubi, an anesthesiologist, created Sleepinox, a natural sleep supplement enhancing sleep, immune system, and cognitive function. The new formula includes magnesium glycinate, valerian root, ashwagandha, borage oil, and L-theanine, avoiding melatonin to prevent depression and morning brain fog. Sleepinox, priced at $45 for 90 capsules, aims to treat insomnia without dependency or morning drowsiness.
pharmavoice.com
·

Specialized CROs aim to boost participation among women and other underrepresented groups

Women remain underrepresented in clinical trials, prompting the launch of Lindus Health's women's health-focused CRO. This CRO aims to address historical gaps by considering ethical and social factors, ensuring true informed consent, and developing strategies to overcome social barriers. Despite increased industry attention, diversity in clinical trials continues to suffer, with underrepresented groups like Black patients, elderly, disabled, indigenous, and transgender and nonbinary people lacking adequate representation. Boosting participation among these groups presents a market opportunity for sponsors.
espn.com
·

Athletes' ADHD, anxiety meds might increase heat stroke risk

Athletic trainer Kenya Moore noticed a player's disorientation after switching ADHD meds, leading to heat stroke. Experts warn that medications for ADHD, anxiety, and depression elevate heat stroke risk in athletes, calling for more research. Heat illness diagnoses and deaths have risen with global temperatures, with stimulants potentially increasing risk by constricting blood vessels and inhibiting sweating. Awareness and precautions are crucial, especially as mental health medication use rises.
© Copyright 2024. All Rights Reserved by MedPath